Follow these directions for how to get rid of a stye and heal faster, courtesy of four eye health experts—plus, when to see a doctor.

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

A high-stakes legal fight between Regeneron and Amgen over the blockbuster eye drug Eylea is putting the U.S. patent system ...

Dr. Claudette Yaméogo is Burkina Faso’s only ophthalmologist who specializes in treating children. She is one of just 70 eye ...

BAYRY's Eylea 8 mg gets CHMP nod in EU, promising 6-month dosing for nAMD and DME with strong 3-year efficacy and safety data.

Regeneron's shares dip as Eylea struggles against competition and FDA rejection, but Dupixent shows robust growth.

Call your doctor right away if you or your baby (if being treated with EYLEA for Retinopathy of Prematurity) experience eye pain or redness, light sensitivity, or a change in vision after an ...

Call your doctor right away if you or your baby (if being treated with EYLEA for Retinopathy of Prematurity) experience eye pain or redness, light sensitivity, or a change in vision after an ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are ...

Call your doctor right away if you or your baby (if being treated with EYLEA for Retinopathy of Prematurity) experience eye pain or redness, light sensitivity, or a change in vision after an injection ...

Unity’s eye treatment failed to match Eylea at 20 weeks—the only time stamp in which the candidate was inferior to Regeneron’s blockbuster.

Earnings Results Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea Anti-inflammatory Dupixent’s sales are up 15%, and a midstage trial of treatment ...